Developing aptamers by cell-based SELEX

Methods in Molecular Biology

Volumn 1380, Issue , 2016, Pages 33-46

  Catuogno, Silvia ^a   Esposito, Carla Lucia ^a   de Franciscis, Vittorio ^a  

^a NONE

Author keywords

Aptamer; Cell SELEX; Glioma; NSCLC; RTK

Indexed keywords

APTAMER; CELL SURFACE PROTEIN; RNA; MEMBRANE PROTEIN; PROTEIN BINDING;

BINDING ASSAY; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LUNG CANCER CELL LINE; MOLECULAR CLONING; NON SMALL CELL LUNG CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TARGET CELL; DNA SEQUENCE; GENE LIBRARY; GLIOMA; METABOLISM; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CLONING, MOLECULAR; GENE LIBRARY; GLIOMA; HUMANS; MEMBRANE PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN BINDING; SELEX APTAMER TECHNIQUE; SEQUENCE ANALYSIS, DNA;

EID: 84946866809     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3197-2_3     Document Type: Chapter

References (24)

1. Cerchia L, de Franciscis V (2010) Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol 28:517-525
2. Missailidis S, Hardy A (2009) Aptamers as inhibitors of target proteins. Expert Opin Ther Pat 19:1073-1082
3. Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9:660
4. Ferreira CS, Matthews CS, Missailidis S (2006) DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1- binding single-stranded DNA aptamers. Tumor Biol 27:289-301
5. Lupold SE, Hicke BJ, Lin Y et al (2002) Identification and characterization of nucleasestabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029-4033
6. Chen CH, Chernis GA, Hoang VQ et al (2003) Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc Natl Acad Sci U S A 100:9226-9231
7. Li N, Larson T, Nguyen HH et al (2010) Directed evolution of gold nanoparticle delivery to cells. Chem Commun (Camb) 46:392-394
8. Ohuchi SP, Ohtsu T, Nakamura Y (2006) Selection of RNA aptamers against recombinant transforming growth factor beta type III receptor displayed on cell surface. Biochimie 88:897-904
9. Chen F, Hu Y, Li D et al (2009) CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2. PLoS One 4:e8142
10. Shangguan D, Li Y, Tang Z et al (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 103:11838-11843
11. Chen HW, Medley CD, Sefah K et al (2008) Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 3:991-1001
12. Sefah K, Meng L, Lopez-Colon D et al (2010) DNA aptamers as molecular probes for colorectal cancer study. PLoS One 5:e14269
13. Thiel KW, Hernandez LI, Dassie JP et al (2012) Delivery of chemo-sensitizing siRNAs to HER2 + -breast cancer cells using RNA aptamers. Nucleic Acids Res 40:6319-6337
14. Thiel WH, Bair T, Peek AS et al (2012) Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. PLoS One 7:e43836
15. Cerchia L, Esposito CL, Jacobs AH et al (2009) Differential SELEX in human glioma cell lines. PLoS One 4:e7971
16. Esposito CL, Passaro D, Longobardo I et al (2011) A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. PLoS One 6:e24071
17. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109D
18. Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97-117
19. Mason WP, Cairncross JG (2008) Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas. Neurology 71:365-373
20. Rao RD, Uhm JH, Krishnan S et al (2003) Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies. Front Biosci 8:e270-e280
21. Sathornsumetee S, Rich JN (2008) Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci 1142:108-132
22. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:877
23. Cerchia L, Esposito CL, Camorani S et al (2012) Targeting Axl with an high-affinity inhibitory aptamer. Mol Ther 20:2291-2303
24. Esposito CL, Cerchia L, Catuogno S et al (2014) Multifunctional aptamer-miRNA conjugates for targeted cancer therapy. Mol Ther 22:1151-1163